I migliori medici di Test di funzionalità tiroidea (inclusi T3, T4, TSH) in Turchia — TOP-52 medici

Il medico si è laureato presso la Facoltà di Medicina dell'Università di Hacettepe e ha completato la residenza presso l'Ospedale di Formazione e Ricerca Sisli Etfal di Istanbul, seguita da una borsa di studio presso l'Istituto di Cancro dell'Università di Hacettepe.<\/p>

Specializzato in oncologia, il medico ha una vasta esperienza nel trattamento di vari tipi di cancro, tra cui il cancro al seno, ai testicoli, alle ovaie, ai polmoni, alla testa e al collo, e al tratto gastrointestinale.<\/p>

Il medico ha lavorato in istituzioni prestigiose come il Centro Oncologico MD Anderson dell'Università del Texas, l'Ospedale di Formazione dell'Università di Hitit a Corum e l'Ospedale Medical Park.<\/p>

Dr. Kezban Berberoglu is a professor of nuclear medicine at Anadolu Medical Center in Istanbul. She completed training at the Johns Hopkins University School of Medicine in Baltimore. Dr. Berberoglu specializes in nuclear oncology and nuclear cardiology. She treats thyroid and prostate cancers using radioisotope therapies. She is a member of the European Association of Nuclear Medicine.

• Performs Lutetium-177 and Actinium-225 therapies for oncology patients.
• Expert in PET-CT imaging using Gallium 68 for oncology cases.
• Member of the Turkish Nuclear Medicine Association cardiology work group.
• Works at an MTQUA Top 10 world hospital affiliated with Johns Hopkins.

Il medico ha completato la formazione medica presso l'Università di Istanbul, Facoltà di Medicina Cerrahpaşa, e ha condotto studi clinici presso il Baylor College of Medicine e la University of Texas Medical School. Ha superato gli esami USMLE e ha ottenuto il Certificato ECFMG per praticare negli Stati Uniti. Dopo essere tornato in Turchia, si è specializzato in chirurgia generale presso l'Università di Istanbul e ha conseguito un diploma in Chirurgia Laparoscopica presso l'Università di Strasburgo. Ha superato l'esame del Consiglio Europeo di Chirurgia Endocrina ed è uno dei cinque chirurghi in Turchia con questa certificazione. Il medico ha oltre 10 anni di esperienza in chirurgia laparoscopica e minimamente invasiva, eseguendo oltre 2000 operazioni di successo.<\/p>

Dr. Zulfu Sertkaya is an associate professor and andrologist at Andro Expertise in Istanbul. He holds the FEBU title from the European Association of Urology. Dr. Sertkaya focuses on male health, sexual function, and aesthetic urological procedures. He treats patients at his clinic and performs surgeries at affiliated hospitals.

• Earned Fellow of the European Board of Urology (FEBU) status.
• Specialize in andrology, male sexual health, and aesthetic urology.
• Performs penile implant surgery and varicocelectomy for infertility.
• Works at a clinic accredited by the Turkish Medical Association.

Il medico si è laureato presso la Scuola di Medicina Cerrahpaşa dell'Università di Istanbul nel 1999 e ha completato una residenza in Medicina Interna lì nel 2005. Specializzandosi ulteriormente in Endocrinologia e Malattie Metaboliche, il medico ha completato una borsa di studio presso l'Università di Selçuk nel 2010 e ha raggiunto la Cattedra Associata nel 2016.<\/p>

Riconosciuto per l'eccellenza nella ricerca scientifica, il medico ha ricevuto premi al Congresso Nazionale sul Diabete e all'Università di Selçuk nel 2014. Con 42 articoli scientifici internazionali e 16 locali, il lavoro è stato citato 230 volte. Il medico ha contribuito a 80 presentazioni e ha partecipato a numerosi progetti scientifici, inclusi quelli finanziati da TUBİTAK.<\/p>

Gli interessi clinici includono il diabete, le malattie della tiroide e i disturbi ormonali.<\/p>

Il dottore si è laureato alla Scuola di Medicina Çapa dell'Università di Istanbul nel 1998 e ha completato una residenza in Radiodiagnostica e Radiologia Interventistica presso la Scuola di Medicina Cerrahpaşa nel 2002. Specializzandosi in Radiologia Diagnostica e Teleradiologia, nonché in Radiologia Interventistica, il dottore ha partecipato a 12 congressi locali e uno internazionale, contribuendo con numerose presentazioni orali e scritte. Il dottore ha ricoperto posizioni presso l'Ospedale Intercontinentale Hisar, l'Ospedale Aereo di Merzifon, il Centro Emar di Istanbul e l'Ospedale di Formazione e Ricerca Haseki.<\/p>

Il medico ha completato la formazione medica presso la Facoltà di Medicina dell'Università di Trakya, la Facoltà di Medicina di Cerrahpaşa e la Facoltà di Medicina dell'Università di Kocaeli. Specializzandosi in endocrinologia, il medico si concentra su diabete, obesità, disturbi della tiroide e malattie della ghiandola pituitaria e delle ghiandole surrenali.<\/p>

Con un solido background accademico, il medico ha contribuito al campo medico con oltre 25 pubblicazioni nazionali e internazionali, dimostrando competenza e impegno per il progresso delle conoscenze mediche in questi settori.<\/p>

Dr. Sezer Saglam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating gastrointestinal and breast cancers. His research on rectal cancer timing has influenced global treatment protocols. Dr. Saglam develops personalized therapy plans using targeted medicine and precision techniques.

• Nominated for the International Best Researcher Award for work on liver cancer.
• Leads clinical trials focused on targeted therapies and precision oncology.
• Member of the American Society of Clinical Oncology (ASCO).
• Certified by the European Society for Medical Oncology (ESMO).

Dr. Saban Sec is a medical oncologist at Valued Med Hub Hospitals in Istanbul. He treats breast, lung, gastrointestinal, and rare tumors. Dr. Sec currently represents specialist physicians in the Turkish Medical Oncology Association. He conducted a significant clinical study involving 138 patients with HER2-positive gastric cancer.

• Expertise covers colorectal, prostate, urogenital, head, neck, and salivary gland cancers.
• Authored over 10 peer-reviewed articles on cancer prognosis and survival rates.
• Member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association.
• Treats patients at a clinic holding the International Health Tourism Authorization Certificate.

Dr. Yusuf Acikgoz is a medical oncologist at Lokman Hekim University Ankara Hospital. He specializes in treating complex cancers, including lung, breast, and liver malignancies. He completed a fellowship at Ohio State University in the United States. Dr. Acikgoz manages treatments like chemotherapy, radioembolization, and immunotherapy.

• Member of the American Society of Clinical Oncology (ASCO).
• Assistant Investigator for Phase III clinical trials, including the CheckMate-649 study.
• Certified in Good Clinical Practice and Human Subjects Protection at Ohio State University.
• Performs diagnostic procedures like biopsy, gastroscopy, and tumor marker testing.

Dr. Bulent Hacimeoglu is the Head of Pediatric Endocrinology at Istanbul Aydin University. He specializes in treating type 2 diabetes, thyroid diseases, and adrenal adenomas in children. Dr. Hacimeoglu is a winner of three oral presentation prizes at National Pediatric Endocrine congresses. He holds a professorship at the Istinye University Faculty of Medicine.

• Member of the European Society of Pediatric Endocrinology (ESPE).
• Specializes in microvascular aging and cardiovascular performance in obese adolescents.
• Treats autoimmune thyroiditis and diffusive-toxic goiter.
• Practices at Valued Med Hub Hospitals, an institution with international health tourism authorization.

Dr. Esra Demir is an internal medicine specialist at Medipol Acibadem District Hospital in Istanbul. She serves as a sub-investigator for major international clinical trials on Type 2 diabetes treatments. Dr. Demir specializes in managing irritable bowel syndrome, thyroid diseases, and diabetes lifestyle changes. She works at a JCI-accredited facility equipped with interventional radiology and robotic systems.

• Led research for cardiovascular outcomes of Semaglutide in diabetic patients.
• Assisted in the SCALE Insulin study for overweight patients with Type 2 diabetes.
• Treats metabolic conditions including anemia, vitamin deficiencies, and adrenal adenomas.
• Performs specialized treatments such as intravenous vitamin C therapy.

Dr. Hakan Duger is an endocrinology specialist at Medical Park Antalya Hospital Complex. He treats metabolic diseases, including type 2 diabetes and adrenal adenoma. Dr. Duger holds double specialization in Internal Medicine and Endocrinology. He serves at the largest private medical center in the Mediterranean region.

• Specializes in thyroid disorders like goiter and autoimmune thyroiditis.
• Expert in managing parathyroid disease and hyperparathyroidism.
• Member of the Turkish Society of Endocrinology and Metabolism.
• Member of the Turkish Diabetes Association.

Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.

• Served as a subinvestigator in over 8 international clinical trials for Roche and Pfizer.
• Authored over 40 research articles in journals indexed by SCI and SSCI.
• Completed dual fellowships in allergy-immunology and medical oncology.
• Treats complex sarcomas and renal cell carcinomas with systemic therapies.

Dr. Gul Alco is a radiation oncologist and Professor at Medipol Acibadem District Hospital in Istanbul. She excels in treating complex cases, including stage 4 lung and liver cancers. Dr. Alco utilizes the CyberKnife and Da Vinci robotic systems for precise tumor targeting. She works at a JCI-accredited facility known for its high safety standards.

• Specializes in brachytherapy and high-intensity focused ultrasound ablation (HIFU).
• Performs radiofrequency ablation and proton-beam therapy for various malignancies.
• Treats pancreatic, breast, ovarian, and brain cancers using targeted radiation.
• Expert in nuclear medicine diagnostics, including PET-CT with Gallium 68.

Dr. Mehmet Fatih Kilicli is the Chief Medical Officer at Medipol Acibadem District Hospital. He specializes in reproductive endocrinology and metabolism. Dr. Kilicli manages endocrine disorders like thyroid cancer, Addison’s disease, and hirsutism. He works at a JCI-accredited facility using the da Vinci robotic system.

• Treats complex conditions including adrenal gland disorders and hyperparathyroidism.
• Performs specialized procedures like radioiodine therapy and thyroidectomy.
• Provides bioidentical hormone replacement therapy (BHRT) and metabolic surgery.
• Offers complex diagnostics like thyroid function tests and premium check-ups.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Tulay Omma is an Associate Professor and endocrinologist at Lokman Hekim Akay Hospital. She won the Best Oral Presentation award for her research on Graves’ Disease. Dr. Omma treats complex thyroid disorders, type 2 diabetes, and adrenal adenomas. She is an active member of the European Society of Endocrinology.

• Published 20+ articles in peer-reviewed journals on metabolic disorders like PCOS.
• Certified in thyroid ultrasonography and clinical trial management.
• Awarded for clinical research on hypoparathyroidism in Turkey.
• Treats patients at a private hospital in Ankara serving 10,000 people annually.